Connor, Clark & Lunn Investment Management (CC&L)
ACH

Connor, Clark & Lunn Investment Management (CC&L)’s Accendra Health ACH Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.41M Sell
1,288,787
-91,941
-7% -$286K 0.01% 770
2026
Q1 		$3.15M Buy
1,380,728
+99,371
+8% +$229K 0.01% 826
2025
Q4 		$3.59M Buy
1,281,357
+354,378
+38% +$1.27M 0.01% 760
2025
Q3 		$4.45M Sell
926,979
-73,986
-7% -$471K 0.01% 610
2025
Q2 		$9.11M Buy
1,000,965
+297,915
+42% +$2.2M 0.03% 423
2025
Q1 		$6.35M Buy
703,050
+401,472
+133% +$4.24M 0.03% 436
2024
Q4 		$3.94M Buy
301,578
+78,504
+35% +$1.05M 0.02% 548
2024
Q3 		$3.5M Buy
223,074
+176,029
+374% +$2.67M 0.02% 529
2024
Q2 		$635K Buy
+47,045
New +$963K ﹤0.01% 983
2023
Q4 		– Sell
-45,297
Closed -$732K – 1512
2023
Q3 		$732K Buy
45,297
+4,435
+11% +$78.7K ﹤0.01% 921
2023
Q2 		$778K Buy
40,862
+27,056
+196% +$483K ﹤0.01% 868
2023
Q1 		$201K Buy
+13,806
New +$247K ﹤0.01% 1096
2022
Q3 		– Sell
-11,421
Closed -$359K – 1212
2022
Q2 		$359K Buy
+11,421
New +$414K ﹤0.01% 837
2021
Q3 		– Sell
-14,254
Closed -$603K – 1171
2021
Q2 		$603K Buy
+14,254
New +$555K ﹤0.01% 756
2019
Q4 		– Sell
-42,525
Closed -$247K – 1046
2019
Q3 		$247K Buy
+42,525
New +$191K ﹤0.01% 828
2018
Q3 		– Sell
-99,175
Closed -$1.66M – 1068
2018
Q2 		$1.66M Buy
99,175
+25,925
+35% +$420K 0.01% 517
2018
Q1 		$1.14M Sell
73,250
-38,225
-34% -$682K 0.01% 464
2017
Q4 		$2.1M Buy
+111,475
New +$2.47M 0.01% 413

Other funds holding ACH

CCM
Coliseum Capital Management Rowayton, Connecticut $1.16B AUM 23.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Connor, Clark & Lunn Investment Management (CC&L)'s ACH Position: Q2 2026 in Review

Connor, Clark & Lunn Investment Management (CC&L) reduced its Accendra Health (ACH) stake by 6.7% in Q2 2026, selling an estimated $286K and leaving 1,288,787 shares worth $4.41M. The position accounts for 0.01% of the portfolio, ranked #770.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in ACH in Q4 2017 and has held it in 18 quarters since. The position peaked at $9.11M in Q2 2025. 139 funds tracked by Wall St. Rank hold ACH as of Q2 2026.

  • Connor, Clark & Lunn Investment Management (CC&L) held 1,288,787 shares of Accendra Health worth $4.41M as of Q2 2026.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 91,941 Accendra Health shares in Q2 2026, an estimated $286K.
  • Accendra Health made up 0.01% of Connor, Clark & Lunn Investment Management (CC&L)'s portfolio in Q2 2026, its #770 holding.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Accendra Health in Q4 2017 and has held it in 18 quarters since.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Accendra Health position peaked at $9.11M in Q2 2025.
  • 139 funds tracked by Wall St. Rank held Accendra Health as of Q2 2026.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2026, filed 13 Aug 2026.